tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Quigley, 29 are a HOLD (55.77%), 20 are a BUY (38.46%), 3 are a SELL (5.77%).
Analyst James Quigley, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 49.26% that have a potential upside of 13.65% achieved within 151 days. Previously, James Quigley worked at JPMORGAN, BERENBERG, MORGAN STANLEY.
James Quigley’s has documented 98 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 03-Jun-2026.
Analyst best performing recommendations are on KYMR (KYMERA THERAPEUTICS).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 1/4/2022. The price target of $67 was fulfilled within 24 days with a profit of $12.77 (23.55%) receiving and performance score of 9.81.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 06-Feb-2024
$17
2 years 8 months 4 days ago
(06-Feb-2024)
3/4 (75%)
$12.45 (273.63%)
250
Buy Since 16-Jun-2023
$17
$-1.96 (-10.34%)
$17
2 years 8 months 5 days ago
(05-Feb-2024)
3/3 (100%)
$-0.27 (-1.56%)
96
Buy Since 16-Jan-2024
2 years 8 months 21 days ago
(19-Jan-2024)
4/7 (57.14%)
$2.7 (41.54%)
490
Buy Since 05-Dec-2023
$8.5
$-10.46 (-55.17%)
$10
2 years 10 months 5 days ago
(05-Dec-2023)
3/4 (75%)
$0.92 (12.14%)
253
Buy Since 05-Dec-2023
$8.5
$-10.46 (-55.17%)
$10
2 years 10 months 5 days ago
(05-Dec-2023)
2/3 (66.67%)
$0.92 (12.14%)
106
Which stock is James Quigley most bullish on?
What Year was the first public recommendation made by James Quigley?
